2
Clinical Trials associated with HY-078020Single-dose tolerability and preliminary PK/PD study of HY-078020 tablets in healthy volunteers
Start Date05 Apr 2024 |
Sponsor / Collaborator- |
HY-078020片在健康志愿者中的单次给药耐受性及初步PK/PD研究
[Translation] Single-dose tolerability and preliminary PK/PD study of HY-078020 tablets in healthy volunteers
主要目的:评估中国健康受试者单次口服不同剂量HY-078020 片后的耐受性和试验目的安全性。
次要目的:评估中国健康受试者单次口服不同剂量HY-078020 片后, HY-078020 片在人体内的药代动力学/药效动力学特征。
[Translation] Primary objective: To evaluate the tolerability and safety of HY-078020 tablets after a single oral administration of different doses in healthy Chinese subjects.
Secondary objective: To evaluate the pharmacokinetic/pharmacodynamic characteristics of HY-078020 tablets in humans after a single oral administration of different doses in healthy Chinese subjects.
100 Clinical Results associated with HY-078020
100 Translational Medicine associated with HY-078020
100 Patents (Medical) associated with HY-078020
100 Deals associated with HY-078020